Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Historical Holders from Q2 2023 to Q3 2025

Symbol
VTGN on Nasdaq
Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
31,887,528
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
23,364,193
Holdings value
$81,815,600
% of all portfolios
0%
Number of holders
58
Number of buys
33
Number of sells
-16
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 13.6% $13,288,797 4,165,767 JANUS HENDERSON GROUP PLC 29 Aug 2025
Nantahala Capital Management, LLC 9.99% 0% $11,308,752 +$1,246,859 3,185,564 +12.4% Nantahala Capital Management, LLC 30 Sep 2025
BIOTECHNOLOGY VALUE FUND L P 9.97% $7,217,318 3,084,324 BVF PARTNERS L P/IL 31 Dec 2024
STEMPOINT CAPITAL LP 8.2% $5,448,671 2,328,492 StemPoint Capital LP 31 Dec 2024
GREAT POINT PARTNERS LLC 6.28% -4.4% $7,298,211 2,055,834 0% Great Point Partners, LLC 30 Sep 2025
VANGUARD GROUP INC 5.5% $5,799,733 1,687,735 The Vanguard Group 30 Sep 2025
ORBIMED ADVISORS LLC 5.34% $5,820,935 1,639,700 ORBIMED CAPITAL LLC 30 Sep 2025

Institutional Holders of Vistagen Therapeutics, Inc. - Common Stock, par value $0.001 per share (VTGN)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 23,364,193 $81,815,600 +$30,638,556 $3.55 58
2025 Q2 14,875,235 $29,750,933 -$917,939 $2 50
2025 Q1 15,325,061 $38,287,272 +$856,836 $2.5 47
2024 Q4 14,903,856 $43,958,204 -$1,103,443 $2.95 54
2024 Q3 14,643,797 $44,079,533 +$4,636,495 $3.01 47
2024 Q2 13,044,677 $45,399,902 -$5,789,213 $3.48 42
2024 Q1 14,613,555 $76,690,483 -$1,575,877 $5.28 41
2023 Q4 14,910,095 $76,226,105 +$50,694,989 $5.14 45
2023 Q3 3,003,814 $15,739,243 +$10,117,983 $5.24 34
2023 Q2 966,706 $1,807,113 +$1,807,113 $1.87 30